The latest price target for MetLife (NYSE:MET) was reported by Barclays on September 4, 2024. The analyst firm set a price target for $91.00 expecting MET to rise to within 12 months (a possible 12.22% upside). 27 analyst firms have reported ratings in the last year.

The latest analyst rating for MetLife (NYSE:MET) was provided by Barclays, and MetLife initiated their overweight rating.

The last upgrade for MetLife Inc happened on January 8, 2024 when Goldman Sachs raised their price target to $80. Goldman Sachs previously had a neutral for MetLife Inc.

The last downgrade for MetLife Inc happened on January 9, 2023 when Goldman Sachs changed their price target from $80 to $78 for MetLife Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MetLife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MetLife was filed on September 4, 2024 so you should expect the next rating to be made available sometime around September 4, 2025.

While ratings are subjective and will change, the latest MetLife (MET) rating was a initiated with a price target of $0.00 to $91.00. The current price MetLife (MET) is trading at is $81.09, which is within the analyst’s predicted range.